tiprankstipranks
CARsgen Therapeutics Holdings Ltd. (HK:2171)
:2171
Hong Kong Market

CARsgen Therapeutics Holdings Ltd. (2171) Income Statement

Compare
1 Followers

CARsgen Therapeutics Holdings Ltd. Income Statement

Last quarter (Q2 2024), CARsgen Therapeutics Holdings Ltd.'s total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q2, CARsgen Therapeutics Holdings Ltd.'s net income was ¥0.00. See CARsgen Therapeutics Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 0.00¥ 0.00¥ 25.81M¥ 0.00¥ 0.00
Gross Profit
¥ 0.00¥ 0.00¥ 25.81M¥ 0.00¥ 0.00
Operating Expenses
¥ 767.65M¥ 802.28M¥ 611.80M¥ 348.67M¥ 230.36M
Depreciation and Amortization
¥ 67.41M¥ 56.92M¥ 52.45M¥ 32.27M¥ 14.28M
EBITDA
¥ -717.64M¥ -793.90M¥ -517.89M¥ -286.17M¥ -206.40M
Operating Income
¥ -767.65M¥ -881.30M¥ -585.99M¥ -327.05M¥ -227.40M
Other Income/Expenses
¥ 20.26M¥ -9.65M¥ -4.16B¥ -737.00M¥ -37.73M
Pretax Income
¥ -747.39M¥ -890.95M¥ -4.74B¥ -1.06B¥ -265.13M
Net Income
¥ -747.79M¥ -892.25M¥ -4.74B¥ -1.80B¥ -304.30M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -1.34¥ -1.62¥ -8.63¥ -8.55¥ -5.36M
Diluted EPS
¥ -1.34¥ -1.62¥ -8.63¥ -8.55¥ -5.36M
Weighted Average Shares Outstanding
556.13M 551.63M 549.89M 210.69M-
Weighted Average Shares Outstanding (Diluted)
556.13M 551.63M 549.89M 210.69M-
Currency in CNY

CARsgen Therapeutics Holdings Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis